✦ LIBER ✦

P.1.191: FACTORS INFLUENCING MUCOSAL HEALING IN CROHN'S DISEASE DURING INFLIXIMAB TREATMENT IN CLINICAL PRACTICE

✍ Scribed by A. Tursi; W. Elisei; G. Giorgetti; A. Penna; P.G. Lecca; L. Di Cesare; G. Brandimarte

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.1.272: CLINICAL RELAPSES AND MUCOSAL H

✍ F. Morace; G. Amalfi; G. Caravelli; M. Di Pierro; M. Schettino; C. Verde; V. Fam 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Tu1150 Association of Serum Infliximab a

✍ Ben-Bassat, Ofer; Romanova, Anna; Iacono, Anna; Irwin, Sue P.; Greenberg, Gordon 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Demographic and clinical parameters infl

✍ Severine Vermeire; Edouard Louis; An Carbonez; Gert Van Assche; Maja Noman; Jacq 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 71 KB

P302 The impact of induction and mainten

✍ J. Kierkus; E. Szymanska; M. Dadalski; A. Wegner; G. Oracz; M. Gorczewska; S. Sz 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 52 KB

Early clinical remission and normalisati

✍ L. S. Kiss; T. Szamosi; T. Molnar; P. Miheller; L. Lakatos; A. Vincze; K. Palatk 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB